nodes	percent_of_prediction	percent_of_DWPC	metapath
Roflumilast—PDE4B—coronary artery disease	0.622	1	CbGaD
Roflumilast—Diarrhoea—Eplerenone—coronary artery disease	0.000167	0.000662	CcSEcCtD
Roflumilast—Fatigue—Perindopril—coronary artery disease	0.000167	0.000662	CcSEcCtD
Roflumilast—Muscle spasms—Lisinopril—coronary artery disease	0.000167	0.00066	CcSEcCtD
Roflumilast—Urticaria—Trandolapril—coronary artery disease	0.000166	0.000658	CcSEcCtD
Roflumilast—Constipation—Perindopril—coronary artery disease	0.000166	0.000656	CcSEcCtD
Roflumilast—Vomiting—Fenofibrate—coronary artery disease	0.000166	0.000656	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Losartan—coronary artery disease	0.000166	0.000656	CcSEcCtD
Roflumilast—Hypersensitivity—Valsartan—coronary artery disease	0.000166	0.000656	CcSEcCtD
Roflumilast—Urticaria—Enalapril—coronary artery disease	0.000166	0.000655	CcSEcCtD
Roflumilast—Abdominal pain—Trandolapril—coronary artery disease	0.000166	0.000654	CcSEcCtD
Roflumilast—Dizziness—Ezetimibe—coronary artery disease	0.000165	0.000654	CcSEcCtD
Roflumilast—Palpitations—Timolol—coronary artery disease	0.000165	0.000654	CcSEcCtD
Roflumilast—Abdominal pain—Enalapril—coronary artery disease	0.000165	0.000652	CcSEcCtD
Roflumilast—Feeling abnormal—Captopril—coronary artery disease	0.000165	0.000652	CcSEcCtD
Roflumilast—Insomnia—Losartan—coronary artery disease	0.000165	0.000651	CcSEcCtD
Roflumilast—Rash—Fenofibrate—coronary artery disease	0.000165	0.000651	CcSEcCtD
Roflumilast—Dermatitis—Fenofibrate—coronary artery disease	0.000164	0.00065	CcSEcCtD
Roflumilast—Decreased appetite—Furosemide—coronary artery disease	0.000164	0.000649	CcSEcCtD
Roflumilast—Headache—Fenofibrate—coronary artery disease	0.000164	0.000647	CcSEcCtD
Roflumilast—Gastrointestinal pain—Captopril—coronary artery disease	0.000164	0.000647	CcSEcCtD
Roflumilast—Urticaria—Telmisartan—coronary artery disease	0.000163	0.000646	CcSEcCtD
Roflumilast—Vomiting—Clopidogrel—coronary artery disease	0.000163	0.000645	CcSEcCtD
Roflumilast—Diarrhoea—Simvastatin—coronary artery disease	0.000163	0.000645	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Furosemide—coronary artery disease	0.000163	0.000644	CcSEcCtD
Roflumilast—Myalgia—Ramipril—coronary artery disease	0.000163	0.000644	CcSEcCtD
Roflumilast—Fatigue—Furosemide—coronary artery disease	0.000163	0.000643	CcSEcCtD
Roflumilast—Tremor—Lisinopril—coronary artery disease	0.000163	0.000643	CcSEcCtD
Roflumilast—Abdominal pain—Telmisartan—coronary artery disease	0.000163	0.000643	CcSEcCtD
Roflumilast—Anxiety—Ramipril—coronary artery disease	0.000162	0.000642	CcSEcCtD
Roflumilast—Vomiting—Lovastatin—coronary artery disease	0.000162	0.000641	CcSEcCtD
Roflumilast—Dizziness—Eplerenone—coronary artery disease	0.000162	0.00064	CcSEcCtD
Roflumilast—Rash—Clopidogrel—coronary artery disease	0.000162	0.00064	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	0.000162	0.00064	CcSEcCtD
Roflumilast—Dermatitis—Clopidogrel—coronary artery disease	0.000162	0.000639	CcSEcCtD
Roflumilast—Asthenia—Valsartan—coronary artery disease	0.000162	0.000639	CcSEcCtD
Roflumilast—Constipation—Furosemide—coronary artery disease	0.000161	0.000638	CcSEcCtD
Roflumilast—Hypersensitivity—Niacin—coronary artery disease	0.000161	0.000638	CcSEcCtD
Roflumilast—Ill-defined disorder—Lisinopril—coronary artery disease	0.000161	0.000637	CcSEcCtD
Roflumilast—Discomfort—Ramipril—coronary artery disease	0.000161	0.000636	CcSEcCtD
Roflumilast—Asthenia—Olmesartan—coronary artery disease	0.000161	0.000636	CcSEcCtD
Roflumilast—Headache—Clopidogrel—coronary artery disease	0.000161	0.000636	CcSEcCtD
Roflumilast—Rash—Lovastatin—coronary artery disease	0.000161	0.000636	CcSEcCtD
Roflumilast—Dermatitis—Lovastatin—coronary artery disease	0.000161	0.000635	CcSEcCtD
Roflumilast—Dyspepsia—Losartan—coronary artery disease	0.00016	0.000634	CcSEcCtD
Roflumilast—Feeling abnormal—Perindopril—coronary artery disease	0.00016	0.000633	CcSEcCtD
Roflumilast—Headache—Lovastatin—coronary artery disease	0.00016	0.000631	CcSEcCtD
Roflumilast—Myalgia—Timolol—coronary artery disease	0.000159	0.00063	CcSEcCtD
Roflumilast—Vomiting—Ezetimibe—coronary artery disease	0.000159	0.000629	CcSEcCtD
Roflumilast—Hypersensitivity—Pravastatin—coronary artery disease	0.000159	0.000628	CcSEcCtD
Roflumilast—Gastrointestinal pain—Perindopril—coronary artery disease	0.000159	0.000628	CcSEcCtD
Roflumilast—Anxiety—Timolol—coronary artery disease	0.000159	0.000627	CcSEcCtD
Roflumilast—Angioedema—Lisinopril—coronary artery disease	0.000159	0.000627	CcSEcCtD
Roflumilast—Decreased appetite—Losartan—coronary artery disease	0.000158	0.000626	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	0.000158	0.000625	CcSEcCtD
Roflumilast—Abdominal pain—Captopril—coronary artery disease	0.000158	0.000625	CcSEcCtD
Roflumilast—Dizziness—Simvastatin—coronary artery disease	0.000158	0.000623	CcSEcCtD
Roflumilast—Rash—Ezetimibe—coronary artery disease	0.000158	0.000623	CcSEcCtD
Roflumilast—Dermatitis—Ezetimibe—coronary artery disease	0.000158	0.000623	CcSEcCtD
Roflumilast—Discomfort—Timolol—coronary artery disease	0.000157	0.000622	CcSEcCtD
Roflumilast—Asthenia—Niacin—coronary artery disease	0.000157	0.000621	CcSEcCtD
Roflumilast—Fatigue—Losartan—coronary artery disease	0.000157	0.000621	CcSEcCtD
Roflumilast—Headache—Ezetimibe—coronary artery disease	0.000157	0.000619	CcSEcCtD
Roflumilast—Malaise—Lisinopril—coronary artery disease	0.000157	0.000619	CcSEcCtD
Roflumilast—Vertigo—Lisinopril—coronary artery disease	0.000156	0.000616	CcSEcCtD
Roflumilast—Constipation—Losartan—coronary artery disease	0.000156	0.000616	CcSEcCtD
Roflumilast—Vomiting—Eplerenone—coronary artery disease	0.000156	0.000615	CcSEcCtD
Roflumilast—Feeling abnormal—Furosemide—coronary artery disease	0.000156	0.000615	CcSEcCtD
Roflumilast—Nausea—Fenofibrate—coronary artery disease	0.000155	0.000613	CcSEcCtD
Roflumilast—Asthenia—Pravastatin—coronary artery disease	0.000155	0.000612	CcSEcCtD
Roflumilast—Gastrointestinal pain—Furosemide—coronary artery disease	0.000154	0.00061	CcSEcCtD
Roflumilast—Rash—Eplerenone—coronary artery disease	0.000154	0.00061	CcSEcCtD
Roflumilast—Urticaria—Perindopril—coronary artery disease	0.000154	0.00061	CcSEcCtD
Roflumilast—Hypersensitivity—Trandolapril—coronary artery disease	0.000154	0.00061	CcSEcCtD
Roflumilast—Dermatitis—Eplerenone—coronary artery disease	0.000154	0.00061	CcSEcCtD
Roflumilast—Diarrhoea—Valsartan—coronary artery disease	0.000154	0.000609	CcSEcCtD
Roflumilast—Hypersensitivity—Enalapril—coronary artery disease	0.000154	0.000607	CcSEcCtD
Roflumilast—Abdominal pain—Perindopril—coronary artery disease	0.000154	0.000607	CcSEcCtD
Roflumilast—Palpitations—Lisinopril—coronary artery disease	0.000153	0.000606	CcSEcCtD
Roflumilast—Diarrhoea—Olmesartan—coronary artery disease	0.000153	0.000606	CcSEcCtD
Roflumilast—Headache—Eplerenone—coronary artery disease	0.000153	0.000606	CcSEcCtD
Roflumilast—Nervous system disorder—Ramipril—coronary artery disease	0.000153	0.000606	CcSEcCtD
Roflumilast—Nausea—Clopidogrel—coronary artery disease	0.000152	0.000603	CcSEcCtD
Roflumilast—Skin disorder—Ramipril—coronary artery disease	0.000152	0.0006	CcSEcCtD
Roflumilast—Infection—Timolol—coronary artery disease	0.000152	0.0006	CcSEcCtD
Roflumilast—Vomiting—Simvastatin—coronary artery disease	0.000152	0.000599	CcSEcCtD
Roflumilast—Hypersensitivity—Telmisartan—coronary artery disease	0.000152	0.000599	CcSEcCtD
Roflumilast—Nausea—Lovastatin—coronary artery disease	0.000151	0.000599	CcSEcCtD
Roflumilast—Rash—Simvastatin—coronary artery disease	0.00015	0.000594	CcSEcCtD
Roflumilast—Dermatitis—Simvastatin—coronary artery disease	0.00015	0.000594	CcSEcCtD
Roflumilast—Asthenia—Trandolapril—coronary artery disease	0.00015	0.000594	CcSEcCtD
Roflumilast—Feeling abnormal—Losartan—coronary artery disease	0.00015	0.000593	CcSEcCtD
Roflumilast—Urticaria—Furosemide—coronary artery disease	0.00015	0.000593	CcSEcCtD
Roflumilast—Diarrhoea—Niacin—coronary artery disease	0.00015	0.000592	CcSEcCtD
Roflumilast—Nervous system disorder—Timolol—coronary artery disease	0.00015	0.000592	CcSEcCtD
Roflumilast—Asthenia—Enalapril—coronary artery disease	0.00015	0.000591	CcSEcCtD
Roflumilast—Headache—Simvastatin—coronary artery disease	0.000149	0.000591	CcSEcCtD
Roflumilast—Abdominal pain—Furosemide—coronary artery disease	0.000149	0.00059	CcSEcCtD
Roflumilast—Gastrointestinal pain—Losartan—coronary artery disease	0.000149	0.000589	CcSEcCtD
Roflumilast—Dizziness—Valsartan—coronary artery disease	0.000149	0.000589	CcSEcCtD
Roflumilast—Nausea—Ezetimibe—coronary artery disease	0.000149	0.000587	CcSEcCtD
Roflumilast—Skin disorder—Timolol—coronary artery disease	0.000148	0.000586	CcSEcCtD
Roflumilast—Dizziness—Olmesartan—coronary artery disease	0.000148	0.000586	CcSEcCtD
Roflumilast—Myalgia—Lisinopril—coronary artery disease	0.000148	0.000584	CcSEcCtD
Roflumilast—Asthenia—Telmisartan—coronary artery disease	0.000148	0.000583	CcSEcCtD
Roflumilast—Diarrhoea—Pravastatin—coronary artery disease	0.000148	0.000583	CcSEcCtD
Roflumilast—Anxiety—Lisinopril—coronary artery disease	0.000147	0.000582	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	0.000147	0.00058	CcSEcCtD
Roflumilast—Discomfort—Lisinopril—coronary artery disease	0.000146	0.000577	CcSEcCtD
Roflumilast—Nausea—Eplerenone—coronary artery disease	0.000145	0.000575	CcSEcCtD
Roflumilast—Dizziness—Niacin—coronary artery disease	0.000145	0.000572	CcSEcCtD
Roflumilast—Urticaria—Losartan—coronary artery disease	0.000145	0.000572	CcSEcCtD
Roflumilast—Abdominal pain—Losartan—coronary artery disease	0.000144	0.000569	CcSEcCtD
Roflumilast—Asthenia—Captopril—coronary artery disease	0.000144	0.000567	CcSEcCtD
Roflumilast—Diarrhoea—Trandolapril—coronary artery disease	0.000143	0.000566	CcSEcCtD
Roflumilast—Vomiting—Valsartan—coronary artery disease	0.000143	0.000566	CcSEcCtD
Roflumilast—Diarrhoea—Enalapril—coronary artery disease	0.000143	0.000564	CcSEcCtD
Roflumilast—Dizziness—Pravastatin—coronary artery disease	0.000143	0.000564	CcSEcCtD
Roflumilast—Vomiting—Olmesartan—coronary artery disease	0.000143	0.000563	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Ramipril—coronary artery disease	0.000142	0.000563	CcSEcCtD
Roflumilast—Rash—Valsartan—coronary artery disease	0.000142	0.000561	CcSEcCtD
Roflumilast—Dermatitis—Valsartan—coronary artery disease	0.000142	0.000561	CcSEcCtD
Roflumilast—Nausea—Simvastatin—coronary artery disease	0.000142	0.00056	CcSEcCtD
Roflumilast—Rash—Olmesartan—coronary artery disease	0.000141	0.000559	CcSEcCtD
Roflumilast—Insomnia—Ramipril—coronary artery disease	0.000141	0.000558	CcSEcCtD
Roflumilast—Dermatitis—Olmesartan—coronary artery disease	0.000141	0.000558	CcSEcCtD
Roflumilast—Headache—Valsartan—coronary artery disease	0.000141	0.000558	CcSEcCtD
Roflumilast—Diarrhoea—Telmisartan—coronary artery disease	0.000141	0.000556	CcSEcCtD
Roflumilast—Infection—Lisinopril—coronary artery disease	0.000141	0.000556	CcSEcCtD
Roflumilast—Headache—Olmesartan—coronary artery disease	0.00014	0.000555	CcSEcCtD
Roflumilast—Asthenia—Perindopril—coronary artery disease	0.000139	0.000551	CcSEcCtD
Roflumilast—Vomiting—Niacin—coronary artery disease	0.000139	0.00055	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Timolol—coronary artery disease	0.000139	0.00055	CcSEcCtD
Roflumilast—Hypersensitivity—Furosemide—coronary artery disease	0.000139	0.00055	CcSEcCtD
Roflumilast—Dizziness—Trandolapril—coronary artery disease	0.000138	0.000547	CcSEcCtD
Roflumilast—Insomnia—Timolol—coronary artery disease	0.000138	0.000546	CcSEcCtD
Roflumilast—Rash—Niacin—coronary artery disease	0.000138	0.000546	CcSEcCtD
Roflumilast—Dermatitis—Niacin—coronary artery disease	0.000138	0.000545	CcSEcCtD
Roflumilast—Dizziness—Enalapril—coronary artery disease	0.000138	0.000545	CcSEcCtD
Roflumilast—Skin disorder—Lisinopril—coronary artery disease	0.000138	0.000544	CcSEcCtD
Roflumilast—Dyspepsia—Ramipril—coronary artery disease	0.000137	0.000544	CcSEcCtD
Roflumilast—Headache—Niacin—coronary artery disease	0.000137	0.000542	CcSEcCtD
Roflumilast—Vomiting—Pravastatin—coronary artery disease	0.000137	0.000542	CcSEcCtD
Roflumilast—Diarrhoea—Captopril—coronary artery disease	0.000137	0.000541	CcSEcCtD
Roflumilast—Dizziness—Telmisartan—coronary artery disease	0.000136	0.000538	CcSEcCtD
Roflumilast—Rash—Pravastatin—coronary artery disease	0.000136	0.000537	CcSEcCtD
Roflumilast—Dermatitis—Pravastatin—coronary artery disease	0.000136	0.000537	CcSEcCtD
Roflumilast—Decreased appetite—Ramipril—coronary artery disease	0.000136	0.000537	CcSEcCtD
Roflumilast—Asthenia—Furosemide—coronary artery disease	0.000135	0.000535	CcSEcCtD
Roflumilast—Headache—Pravastatin—coronary artery disease	0.000135	0.000534	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Ramipril—coronary artery disease	0.000135	0.000533	CcSEcCtD
Roflumilast—Fatigue—Ramipril—coronary artery disease	0.000135	0.000532	CcSEcCtD
Roflumilast—Dyspepsia—Timolol—coronary artery disease	0.000134	0.000531	CcSEcCtD
Roflumilast—Hypersensitivity—Losartan—coronary artery disease	0.000134	0.000531	CcSEcCtD
Roflumilast—Nausea—Valsartan—coronary artery disease	0.000134	0.000529	CcSEcCtD
Roflumilast—Constipation—Ramipril—coronary artery disease	0.000134	0.000528	CcSEcCtD
Roflumilast—Nausea—Olmesartan—coronary artery disease	0.000133	0.000526	CcSEcCtD
Roflumilast—Vomiting—Trandolapril—coronary artery disease	0.000133	0.000526	CcSEcCtD
Roflumilast—Diarrhoea—Perindopril—coronary artery disease	0.000133	0.000525	CcSEcCtD
Roflumilast—Decreased appetite—Timolol—coronary artery disease	0.000133	0.000525	CcSEcCtD
Roflumilast—Vomiting—Enalapril—coronary artery disease	0.000133	0.000524	CcSEcCtD
Roflumilast—Dizziness—Captopril—coronary artery disease	0.000132	0.000523	CcSEcCtD
Roflumilast—Rash—Trandolapril—coronary artery disease	0.000132	0.000522	CcSEcCtD
Roflumilast—Dermatitis—Trandolapril—coronary artery disease	0.000132	0.000521	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Timolol—coronary artery disease	0.000132	0.000521	CcSEcCtD
Roflumilast—Fatigue—Timolol—coronary artery disease	0.000132	0.00052	CcSEcCtD
Roflumilast—Rash—Enalapril—coronary artery disease	0.000131	0.00052	CcSEcCtD
Roflumilast—Dermatitis—Enalapril—coronary artery disease	0.000131	0.000519	CcSEcCtD
Roflumilast—Headache—Trandolapril—coronary artery disease	0.000131	0.000519	CcSEcCtD
Roflumilast—Vomiting—Telmisartan—coronary artery disease	0.000131	0.000517	CcSEcCtD
Roflumilast—Asthenia—Losartan—coronary artery disease	0.000131	0.000517	CcSEcCtD
Roflumilast—Headache—Enalapril—coronary artery disease	0.000131	0.000516	CcSEcCtD
Roflumilast—Nausea—Niacin—coronary artery disease	0.00013	0.000514	CcSEcCtD
Roflumilast—Rash—Telmisartan—coronary artery disease	0.00013	0.000513	CcSEcCtD
Roflumilast—Dermatitis—Telmisartan—coronary artery disease	0.00013	0.000512	CcSEcCtD
Roflumilast—Diarrhoea—Furosemide—coronary artery disease	0.000129	0.000511	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Lisinopril—coronary artery disease	0.000129	0.00051	CcSEcCtD
Roflumilast—Headache—Telmisartan—coronary artery disease	0.000129	0.000509	CcSEcCtD
Roflumilast—Feeling abnormal—Ramipril—coronary artery disease	0.000129	0.000509	CcSEcCtD
Roflumilast—Dizziness—Perindopril—coronary artery disease	0.000128	0.000508	CcSEcCtD
Roflumilast—Insomnia—Lisinopril—coronary artery disease	0.000128	0.000506	CcSEcCtD
Roflumilast—Nausea—Pravastatin—coronary artery disease	0.000128	0.000506	CcSEcCtD
Roflumilast—Gastrointestinal pain—Ramipril—coronary artery disease	0.000128	0.000505	CcSEcCtD
Roflumilast—Vomiting—Captopril—coronary artery disease	0.000127	0.000503	CcSEcCtD
Roflumilast—Rash—Captopril—coronary artery disease	0.000126	0.000499	CcSEcCtD
Roflumilast—Dermatitis—Captopril—coronary artery disease	0.000126	0.000498	CcSEcCtD
Roflumilast—Feeling abnormal—Timolol—coronary artery disease	0.000126	0.000497	CcSEcCtD
Roflumilast—Headache—Captopril—coronary artery disease	0.000125	0.000495	CcSEcCtD
Roflumilast—Gastrointestinal pain—Timolol—coronary artery disease	0.000125	0.000494	CcSEcCtD
Roflumilast—Dizziness—Furosemide—coronary artery disease	0.000125	0.000494	CcSEcCtD
Roflumilast—Dyspepsia—Lisinopril—coronary artery disease	0.000125	0.000493	CcSEcCtD
Roflumilast—Diarrhoea—Losartan—coronary artery disease	0.000125	0.000493	CcSEcCtD
Roflumilast—Nausea—Trandolapril—coronary artery disease	0.000124	0.000492	CcSEcCtD
Roflumilast—Urticaria—Ramipril—coronary artery disease	0.000124	0.000491	CcSEcCtD
Roflumilast—Nausea—Enalapril—coronary artery disease	0.000124	0.00049	CcSEcCtD
Roflumilast—Vomiting—Perindopril—coronary artery disease	0.000123	0.000488	CcSEcCtD
Roflumilast—Abdominal pain—Ramipril—coronary artery disease	0.000123	0.000488	CcSEcCtD
Roflumilast—Decreased appetite—Lisinopril—coronary artery disease	0.000123	0.000487	CcSEcCtD
Roflumilast—Rash—Perindopril—coronary artery disease	0.000122	0.000484	CcSEcCtD
Roflumilast—Dermatitis—Perindopril—coronary artery disease	0.000122	0.000484	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Lisinopril—coronary artery disease	0.000122	0.000483	CcSEcCtD
Roflumilast—Nausea—Telmisartan—coronary artery disease	0.000122	0.000483	CcSEcCtD
Roflumilast—Fatigue—Lisinopril—coronary artery disease	0.000122	0.000483	CcSEcCtD
Roflumilast—Headache—Perindopril—coronary artery disease	0.000122	0.000481	CcSEcCtD
Roflumilast—Urticaria—Timolol—coronary artery disease	0.000121	0.00048	CcSEcCtD
Roflumilast—Constipation—Lisinopril—coronary artery disease	0.000121	0.000479	CcSEcCtD
Roflumilast—Abdominal pain—Timolol—coronary artery disease	0.000121	0.000477	CcSEcCtD
Roflumilast—Dizziness—Losartan—coronary artery disease	0.00012	0.000476	CcSEcCtD
Roflumilast—Vomiting—Furosemide—coronary artery disease	0.00012	0.000475	CcSEcCtD
Roflumilast—Rash—Furosemide—coronary artery disease	0.000119	0.000471	CcSEcCtD
Roflumilast—Dermatitis—Furosemide—coronary artery disease	0.000119	0.00047	CcSEcCtD
Roflumilast—Nausea—Captopril—coronary artery disease	0.000119	0.00047	CcSEcCtD
Roflumilast—Headache—Furosemide—coronary artery disease	0.000118	0.000468	CcSEcCtD
Roflumilast—Feeling abnormal—Lisinopril—coronary artery disease	0.000117	0.000461	CcSEcCtD
Roflumilast—Gastrointestinal pain—Lisinopril—coronary artery disease	0.000116	0.000458	CcSEcCtD
Roflumilast—Vomiting—Losartan—coronary artery disease	0.000116	0.000458	CcSEcCtD
Roflumilast—Nausea—Perindopril—coronary artery disease	0.000115	0.000456	CcSEcCtD
Roflumilast—Hypersensitivity—Ramipril—coronary artery disease	0.000115	0.000455	CcSEcCtD
Roflumilast—Rash—Losartan—coronary artery disease	0.000115	0.000454	CcSEcCtD
Roflumilast—Dermatitis—Losartan—coronary artery disease	0.000115	0.000454	CcSEcCtD
Roflumilast—Headache—Losartan—coronary artery disease	0.000114	0.000451	CcSEcCtD
Roflumilast—Urticaria—Lisinopril—coronary artery disease	0.000113	0.000445	CcSEcCtD
Roflumilast—Hypersensitivity—Timolol—coronary artery disease	0.000112	0.000445	CcSEcCtD
Roflumilast—Nausea—Furosemide—coronary artery disease	0.000112	0.000443	CcSEcCtD
Roflumilast—Asthenia—Ramipril—coronary artery disease	0.000112	0.000443	CcSEcCtD
Roflumilast—Abdominal pain—Lisinopril—coronary artery disease	0.000112	0.000443	CcSEcCtD
Roflumilast—Asthenia—Timolol—coronary artery disease	0.00011	0.000433	CcSEcCtD
Roflumilast—Nausea—Losartan—coronary artery disease	0.000108	0.000428	CcSEcCtD
Roflumilast—Diarrhoea—Ramipril—coronary artery disease	0.000107	0.000422	CcSEcCtD
Roflumilast—Diarrhoea—Timolol—coronary artery disease	0.000104	0.000413	CcSEcCtD
Roflumilast—Hypersensitivity—Lisinopril—coronary artery disease	0.000104	0.000413	CcSEcCtD
Roflumilast—Dizziness—Ramipril—coronary artery disease	0.000103	0.000408	CcSEcCtD
Roflumilast—Asthenia—Lisinopril—coronary artery disease	0.000102	0.000402	CcSEcCtD
Roflumilast—Dizziness—Timolol—coronary artery disease	0.000101	0.000399	CcSEcCtD
Roflumilast—Vomiting—Ramipril—coronary artery disease	9.93e-05	0.000393	CcSEcCtD
Roflumilast—Rash—Ramipril—coronary artery disease	9.85e-05	0.000389	CcSEcCtD
Roflumilast—Dermatitis—Ramipril—coronary artery disease	9.84e-05	0.000389	CcSEcCtD
Roflumilast—Headache—Ramipril—coronary artery disease	9.78e-05	0.000387	CcSEcCtD
Roflumilast—Vomiting—Timolol—coronary artery disease	9.71e-05	0.000384	CcSEcCtD
Roflumilast—Diarrhoea—Lisinopril—coronary artery disease	9.69e-05	0.000383	CcSEcCtD
Roflumilast—Rash—Timolol—coronary artery disease	9.63e-05	0.000381	CcSEcCtD
Roflumilast—Dermatitis—Timolol—coronary artery disease	9.62e-05	0.00038	CcSEcCtD
Roflumilast—Headache—Timolol—coronary artery disease	9.57e-05	0.000378	CcSEcCtD
Roflumilast—Dizziness—Lisinopril—coronary artery disease	9.37e-05	0.00037	CcSEcCtD
Roflumilast—Nausea—Ramipril—coronary artery disease	9.28e-05	0.000367	CcSEcCtD
Roflumilast—Nausea—Timolol—coronary artery disease	9.07e-05	0.000359	CcSEcCtD
Roflumilast—Vomiting—Lisinopril—coronary artery disease	9.01e-05	0.000356	CcSEcCtD
Roflumilast—Rash—Lisinopril—coronary artery disease	8.93e-05	0.000353	CcSEcCtD
Roflumilast—Dermatitis—Lisinopril—coronary artery disease	8.92e-05	0.000353	CcSEcCtD
Roflumilast—Headache—Lisinopril—coronary artery disease	8.87e-05	0.000351	CcSEcCtD
Roflumilast—Nausea—Lisinopril—coronary artery disease	8.41e-05	0.000333	CcSEcCtD
Roflumilast—PDE4A—Signaling by GPCR—CCL2—coronary artery disease	2.62e-05	0.00021	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—HTR7—coronary artery disease	2.61e-05	0.000209	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—S100B—coronary artery disease	2.61e-05	0.000209	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—IL6R—coronary artery disease	2.61e-05	0.000209	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CXCL10—coronary artery disease	2.61e-05	0.000209	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PLG—coronary artery disease	2.6e-05	0.000208	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—SOCS3—coronary artery disease	2.59e-05	0.000207	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—ITGB3—coronary artery disease	2.56e-05	0.000205	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—TGFBR2—coronary artery disease	2.56e-05	0.000205	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—KITLG—coronary artery disease	2.56e-05	0.000205	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—ADRB2—coronary artery disease	2.53e-05	0.000203	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PRKCE—coronary artery disease	2.5e-05	0.0002	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—MMP3—coronary artery disease	2.5e-05	0.0002	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—STAT5A—coronary artery disease	2.5e-05	0.0002	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—CXCL8—coronary artery disease	2.5e-05	0.0002	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—JAK2—coronary artery disease	2.5e-05	0.0002	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—SOCS1—coronary artery disease	2.49e-05	0.0002	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—ITGAV—coronary artery disease	2.49e-05	0.0002	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—S100B—coronary artery disease	2.49e-05	0.000199	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PPP2CA—coronary artery disease	2.49e-05	0.000199	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—KNG1—coronary artery disease	2.48e-05	0.000199	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—POMC—coronary artery disease	2.48e-05	0.000198	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—CREB1—coronary artery disease	2.48e-05	0.000198	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—AGTR1—coronary artery disease	2.47e-05	0.000198	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—SOCS3—coronary artery disease	2.46e-05	0.000197	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PRKCD—coronary artery disease	2.44e-05	0.000195	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—KITLG—coronary artery disease	2.43e-05	0.000195	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—TGFBR2—coronary artery disease	2.43e-05	0.000195	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—CCL2—coronary artery disease	2.42e-05	0.000194	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—APOB—coronary artery disease	2.42e-05	0.000193	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—IL6R—coronary artery disease	2.42e-05	0.000193	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CXCL10—coronary artery disease	2.41e-05	0.000193	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PLG—coronary artery disease	2.41e-05	0.000193	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—CXCL8—coronary artery disease	2.39e-05	0.000192	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—HTR2A—coronary artery disease	2.39e-05	0.000191	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—C3—coronary artery disease	2.39e-05	0.000191	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—JAK2—coronary artery disease	2.38e-05	0.000191	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—STAT5A—coronary artery disease	2.38e-05	0.00019	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—MMP3—coronary artery disease	2.38e-05	0.00019	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—EDN1—coronary artery disease	2.38e-05	0.00019	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CCL5—coronary artery disease	2.36e-05	0.000189	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—ADRB2—coronary artery disease	2.34e-05	0.000188	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—FGF1—coronary artery disease	2.32e-05	0.000186	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CSF2—coronary artery disease	2.32e-05	0.000186	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PRKCE—coronary artery disease	2.31e-05	0.000185	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—JAK2—coronary artery disease	2.31e-05	0.000185	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—SOCS1—coronary artery disease	2.31e-05	0.000185	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—LPL—coronary artery disease	2.31e-05	0.000185	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—S100B—coronary artery disease	2.3e-05	0.000184	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—APOB—coronary artery disease	2.3e-05	0.000184	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—RPS6KB1—coronary artery disease	2.29e-05	0.000183	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—MEF2C—coronary artery disease	2.29e-05	0.000183	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—CXCL8—coronary artery disease	2.28e-05	0.000183	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—SOCS3—coronary artery disease	2.28e-05	0.000182	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—HIF1A—coronary artery disease	2.27e-05	0.000182	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—JAK2—coronary artery disease	2.27e-05	0.000182	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—AGT—coronary artery disease	2.27e-05	0.000181	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—EDN1—coronary artery disease	2.26e-05	0.000181	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—KITLG—coronary artery disease	2.25e-05	0.00018	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—TGFBR2—coronary artery disease	2.25e-05	0.00018	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CCL5—coronary artery disease	2.25e-05	0.00018	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—ITGB3—coronary artery disease	2.23e-05	0.000178	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—APOE—coronary artery disease	2.22e-05	0.000178	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—LEP—coronary artery disease	2.22e-05	0.000178	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CSF2—coronary artery disease	2.21e-05	0.000177	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—FGF1—coronary artery disease	2.21e-05	0.000177	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—MMP3—coronary artery disease	2.2e-05	0.000176	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—STAT5A—coronary artery disease	2.2e-05	0.000176	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—LPL—coronary artery disease	2.2e-05	0.000176	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—APOA1—coronary artery disease	2.2e-05	0.000176	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—RPS6KB1—coronary artery disease	2.18e-05	0.000174	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—KDR—coronary artery disease	2.18e-05	0.000174	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—MEF2C—coronary artery disease	2.18e-05	0.000174	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—CXCL8—coronary artery disease	2.17e-05	0.000174	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PPP2CA—coronary artery disease	2.16e-05	0.000173	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—MAPK14—coronary artery disease	2.16e-05	0.000173	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—APOB—coronary artery disease	2.13e-05	0.00017	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PRKCD—coronary artery disease	2.12e-05	0.00017	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—ITGB3—coronary artery disease	2.12e-05	0.00017	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—ESR1—coronary artery disease	2.12e-05	0.00017	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—CXCL8—coronary artery disease	2.11e-05	0.000169	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—JAK2—coronary artery disease	2.1e-05	0.000168	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—F2—coronary artery disease	2.09e-05	0.000168	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—FN1—coronary artery disease	2.09e-05	0.000168	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—EDN1—coronary artery disease	2.09e-05	0.000168	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—IL6ST—coronary artery disease	2.09e-05	0.000167	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—HTR2A—coronary artery disease	2.08e-05	0.000167	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CCL5—coronary artery disease	2.08e-05	0.000166	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—C3—coronary artery disease	2.08e-05	0.000166	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—CXCL8—coronary artery disease	2.07e-05	0.000166	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—NFKBIA—coronary artery disease	2.07e-05	0.000166	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PPP2CA—coronary artery disease	2.06e-05	0.000165	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CSF2—coronary artery disease	2.05e-05	0.000164	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—FGF1—coronary artery disease	2.05e-05	0.000164	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—LPL—coronary artery disease	2.03e-05	0.000163	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PRKCD—coronary artery disease	2.02e-05	0.000162	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—MEF2C—coronary artery disease	2.01e-05	0.000161	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—RPS6KB1—coronary artery disease	2.01e-05	0.000161	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—KIT—coronary artery disease	2e-05	0.00016	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—HIF1A—coronary artery disease	1.98e-05	0.000159	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—HTR2A—coronary artery disease	1.98e-05	0.000158	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—C3—coronary artery disease	1.98e-05	0.000158	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—AGT—coronary artery disease	1.97e-05	0.000158	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—ITGB3—coronary artery disease	1.96e-05	0.000157	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—APOE—coronary artery disease	1.93e-05	0.000155	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—LEP—coronary artery disease	1.93e-05	0.000155	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—GSK3B—coronary artery disease	1.92e-05	0.000154	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—CXCL8—coronary artery disease	1.92e-05	0.000153	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—APOA1—coronary artery disease	1.91e-05	0.000153	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—POMC—coronary artery disease	1.91e-05	0.000153	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CREB1—coronary artery disease	1.91e-05	0.000153	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PPP2CA—coronary artery disease	1.91e-05	0.000153	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—KDR—coronary artery disease	1.89e-05	0.000152	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—HIF1A—coronary artery disease	1.88e-05	0.000151	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—MAPK14—coronary artery disease	1.88e-05	0.000151	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—AGT—coronary artery disease	1.88e-05	0.00015	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PRKCD—coronary artery disease	1.87e-05	0.00015	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CCL2—coronary artery disease	1.87e-05	0.000149	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—IL6R—coronary artery disease	1.86e-05	0.000149	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—ESR1—coronary artery disease	1.85e-05	0.000148	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—APOE—coronary artery disease	1.84e-05	0.000147	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—LEP—coronary artery disease	1.84e-05	0.000147	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—IGF1—coronary artery disease	1.84e-05	0.000147	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—HTR2A—coronary artery disease	1.83e-05	0.000147	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—C3—coronary artery disease	1.83e-05	0.000146	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—MAPK1—coronary artery disease	1.83e-05	0.000146	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—F2—coronary artery disease	1.82e-05	0.000146	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—FN1—coronary artery disease	1.82e-05	0.000146	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—APOA1—coronary artery disease	1.82e-05	0.000146	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—IL6ST—coronary artery disease	1.82e-05	0.000145	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—KDR—coronary artery disease	1.8e-05	0.000144	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—NFKBIA—coronary artery disease	1.8e-05	0.000144	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—MAPK14—coronary artery disease	1.79e-05	0.000143	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—ESR1—coronary artery disease	1.76e-05	0.000141	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—PIK3CA—coronary artery disease	1.75e-05	0.00014	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—KIT—coronary artery disease	1.74e-05	0.00014	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—HIF1A—coronary artery disease	1.74e-05	0.00014	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—SERPINE1—coronary artery disease	1.74e-05	0.00014	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—AGT—coronary artery disease	1.74e-05	0.000139	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—F2—coronary artery disease	1.74e-05	0.000139	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—FN1—coronary artery disease	1.74e-05	0.000139	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—IL6ST—coronary artery disease	1.73e-05	0.000138	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—NFKBIA—coronary artery disease	1.71e-05	0.000137	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—LEP—coronary artery disease	1.7e-05	0.000136	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—APOE—coronary artery disease	1.7e-05	0.000136	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—FGF2—coronary artery disease	1.69e-05	0.000135	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—APOA1—coronary artery disease	1.68e-05	0.000135	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—GSK3B—coronary artery disease	1.67e-05	0.000134	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—KDR—coronary artery disease	1.67e-05	0.000134	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—NOS3—coronary artery disease	1.66e-05	0.000133	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—POMC—coronary artery disease	1.66e-05	0.000133	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CREB1—coronary artery disease	1.66e-05	0.000133	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—KIT—coronary artery disease	1.66e-05	0.000133	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—MAPK14—coronary artery disease	1.66e-05	0.000133	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—ESR1—coronary artery disease	1.63e-05	0.00013	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CCL2—coronary artery disease	1.62e-05	0.00013	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—IL6R—coronary artery disease	1.62e-05	0.00013	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—JAK2—coronary artery disease	1.62e-05	0.000129	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—F2—coronary artery disease	1.61e-05	0.000129	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—FN1—coronary artery disease	1.61e-05	0.000129	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—IL6ST—coronary artery disease	1.6e-05	0.000128	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—IGF1—coronary artery disease	1.6e-05	0.000128	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—GSK3B—coronary artery disease	1.59e-05	0.000128	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—MAPK1—coronary artery disease	1.59e-05	0.000127	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—NFKBIA—coronary artery disease	1.59e-05	0.000127	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—PIK3CA—coronary artery disease	1.58e-05	0.000127	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—POMC—coronary artery disease	1.58e-05	0.000127	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CREB1—coronary artery disease	1.58e-05	0.000127	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CCL2—coronary artery disease	1.55e-05	0.000124	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—IL6R—coronary artery disease	1.54e-05	0.000123	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—KIT—coronary artery disease	1.54e-05	0.000123	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—IGF1—coronary artery disease	1.52e-05	0.000122	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—PIK3CA—coronary artery disease	1.52e-05	0.000122	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—SERPINE1—coronary artery disease	1.52e-05	0.000121	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—MAPK1—coronary artery disease	1.51e-05	0.000121	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CXCL8—coronary artery disease	1.48e-05	0.000118	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—GSK3B—coronary artery disease	1.47e-05	0.000118	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—FGF2—coronary artery disease	1.47e-05	0.000118	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—POMC—coronary artery disease	1.46e-05	0.000117	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CREB1—coronary artery disease	1.46e-05	0.000117	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—NOS3—coronary artery disease	1.45e-05	0.000116	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—PIK3CA—coronary artery disease	1.45e-05	0.000116	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—SERPINE1—coronary artery disease	1.44e-05	0.000116	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CCL2—coronary artery disease	1.43e-05	0.000115	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—IL6R—coronary artery disease	1.43e-05	0.000114	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—AKT1—coronary artery disease	1.43e-05	0.000114	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CASP3—coronary artery disease	1.41e-05	0.000113	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—JAK2—coronary artery disease	1.41e-05	0.000113	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—IGF1—coronary artery disease	1.41e-05	0.000113	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—IL6—coronary artery disease	1.4e-05	0.000112	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—MAPK1—coronary artery disease	1.4e-05	0.000112	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—FGF2—coronary artery disease	1.4e-05	0.000112	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—PIK3CA—coronary artery disease	1.38e-05	0.00011	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—NOS3—coronary artery disease	1.38e-05	0.00011	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CCND1—coronary artery disease	1.37e-05	0.00011	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—JAK2—coronary artery disease	1.34e-05	0.000107	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—PIK3CA—coronary artery disease	1.34e-05	0.000107	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—SERPINE1—coronary artery disease	1.34e-05	0.000107	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—MMP9—coronary artery disease	1.33e-05	0.000107	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—PIK3CA—coronary artery disease	1.31e-05	0.000105	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—AKT1—coronary artery disease	1.29e-05	0.000104	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—FGF2—coronary artery disease	1.29e-05	0.000104	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CXCL8—coronary artery disease	1.28e-05	0.000103	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—NOS3—coronary artery disease	1.28e-05	0.000102	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—AKT1—coronary artery disease	1.24e-05	9.94e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—JAK2—coronary artery disease	1.24e-05	9.93e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CASP3—coronary artery disease	1.23e-05	9.85e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CXCL8—coronary artery disease	1.22e-05	9.79e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—IL6—coronary artery disease	1.22e-05	9.78e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—PIK3CA—coronary artery disease	1.22e-05	9.73e-05	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—VEGFA—coronary artery disease	1.2e-05	9.6e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CCND1—coronary artery disease	1.2e-05	9.58e-05	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—AKT1—coronary artery disease	1.18e-05	9.46e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CASP3—coronary artery disease	1.17e-05	9.37e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—IL6—coronary artery disease	1.16e-05	9.31e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—MMP9—coronary artery disease	1.16e-05	9.3e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CCND1—coronary artery disease	1.14e-05	9.12e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CXCL8—coronary artery disease	1.13e-05	9.06e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—AKT1—coronary artery disease	1.13e-05	9.02e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—MMP9—coronary artery disease	1.11e-05	8.86e-05	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—TGFB1—coronary artery disease	1.1e-05	8.81e-05	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—AKT1—coronary artery disease	1.09e-05	8.75e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CASP3—coronary artery disease	1.08e-05	8.67e-05	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—MAPK1—coronary artery disease	1.08e-05	8.64e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—IL6—coronary artery disease	1.08e-05	8.61e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—AKT1—coronary artery disease	1.07e-05	8.59e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CCND1—coronary artery disease	1.05e-05	8.44e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—VEGFA—coronary artery disease	1.04e-05	8.35e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—MMP9—coronary artery disease	1.02e-05	8.19e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—VEGFA—coronary artery disease	9.93e-06	7.95e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—AKT1—coronary artery disease	9.93e-06	7.95e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—TGFB1—coronary artery disease	9.58e-06	7.67e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—MAPK1—coronary artery disease	9.39e-06	7.52e-05	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PIK3CA—coronary artery disease	9.36e-06	7.5e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—VEGFA—coronary artery disease	9.19e-06	7.36e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—TGFB1—coronary artery disease	9.12e-06	7.3e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—MAPK1—coronary artery disease	8.94e-06	7.16e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—TGFB1—coronary artery disease	8.43e-06	6.75e-05	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—IL6—coronary artery disease	8.29e-06	6.64e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—MAPK1—coronary artery disease	8.27e-06	6.62e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PIK3CA—coronary artery disease	8.15e-06	6.53e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PIK3CA—coronary artery disease	7.76e-06	6.21e-05	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—AKT1—coronary artery disease	7.65e-06	6.12e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—IL6—coronary artery disease	7.22e-06	5.78e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PIK3CA—coronary artery disease	7.18e-06	5.75e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—IL6—coronary artery disease	6.87e-06	5.5e-05	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—AKT1—coronary artery disease	6.66e-06	5.33e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—IL6—coronary artery disease	6.36e-06	5.09e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—AKT1—coronary artery disease	6.34e-06	5.07e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—AKT1—coronary artery disease	5.86e-06	4.69e-05	CbGpPWpGaD
